308 related articles for article (PubMed ID: 37452331)
1. Overexpression of POLA2 in hepatocellular carcinoma is involved in immune infiltration and predicts a poor prognosis.
Liu L; Wang Q; Wu L; Zhang L; Huang Y; Yang H; Guo L; Fang Z; Wang X
Cancer Cell Int; 2023 Jul; 23(1):138. PubMed ID: 37452331
[TBL] [Abstract][Full Text] [Related]
2. The Biological Function of POLA2 in Hepatocellular Carcinoma.
Yang Z; Shen X; Wang Z; Li R; Hou W; Liu Z; Gao Y; Zhu C; Qin X
Comb Chem High Throughput Screen; 2023 Oct; ():. PubMed ID: 37861044
[TBL] [Abstract][Full Text] [Related]
3. E2F-mediated POLA2 upregulation is correlated with macrophage infiltration and poor prognosis in hepatocellular carcinoma.
Teng Y; Liu R
Transl Cancer Res; 2024 Apr; 13(4):1848-1860. PubMed ID: 38737703
[TBL] [Abstract][Full Text] [Related]
4. CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma.
Su J; Huang Y; Wang Y; Li R; Deng W; Zhang H; Xiong H
Cancer Cell Int; 2022 Feb; 22(1):67. PubMed ID: 35139863
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of the tumor-promoting effect and immune infiltration correlation MAZ from pan-cancer to hepatocellular carcinoma.
Wang M; Yang X; Meng Y; Jin Z; Cao J; Xiong L; Xiong Z
Int Immunopharmacol; 2023 Feb; 115():109660. PubMed ID: 36623412
[TBL] [Abstract][Full Text] [Related]
6. Identification of PDCD1 and PDCD1LG2 as Prognostic Biomarkers and Associated with Immune Infiltration in Hepatocellular Carcinoma.
Li W; Mei M; Liu T; Zhang S; Wang Z; Suo Y; Wang S; Liu Y; Zhang N; Lu W
Int J Gen Med; 2022; 15():437-449. PubMed ID: 35046705
[TBL] [Abstract][Full Text] [Related]
7. High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma.
Wang X; Xing Z; Chen H; Yang H; Wang Q; Xing T
Front Oncol; 2022; 12():953529. PubMed ID: 36059705
[TBL] [Abstract][Full Text] [Related]
8. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma.
Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C
J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201
[TBL] [Abstract][Full Text] [Related]
9. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma.
Tian F; Cai D
Gene; 2022 Jan; 807():145964. PubMed ID: 34530087
[TBL] [Abstract][Full Text] [Related]
10. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
11. [The Expression of RTN1 in Lung Adenocarcinoma and
Its Effect on Immune Microenvironment].
Zhu S; Zu L; Xu S
Zhongguo Fei Ai Za Zhi; 2022 Jun; 25(6):385-395. PubMed ID: 35747917
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of
Yang P; Liu H; Li Y; Gao Q; Chen X; Chang J; Li Y; Chen S; Dong R; Wu H; Liu C; Liu G
Front Genet; 2022; 13():959832. PubMed ID: 36299588
[No Abstract] [Full Text] [Related]
13. Exploring Prognosis, Tumor Microenvironment and Tumor Immune Infiltration in Hepatocellular Carcinoma Based on ATF/CREB Transcription Factor Family Gene-Related Model.
Shen H; Gu X; Li H; Tang M; Li X; Zhang Y; Su F; Wang Z
J Hepatocell Carcinoma; 2023; 10():327-345. PubMed ID: 36874250
[TBL] [Abstract][Full Text] [Related]
14. Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma.
Zhang W; Kong HF; Gao XD; Dong Z; Lu Y; Huang JG; Li H; Yang YP
World J Gastroenterol; 2020 Sep; 26(35):5287-5301. PubMed ID: 32994688
[TBL] [Abstract][Full Text] [Related]
15. Exonuclease 1 is a Potential Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma.
Ma J; Jin J; Lu H; Zhang J; Li Y; Cai X
Front Mol Biosci; 2022; 9():889414. PubMed ID: 35769911
[No Abstract] [Full Text] [Related]
16. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
[TBL] [Abstract][Full Text] [Related]
17. H2AFZ Is a Prognostic Biomarker Correlated to TP53 Mutation and Immune Infiltration in Hepatocellular Carcinoma.
Dong M; Chen J; Deng Y; Zhang D; Dong L; Sun D
Front Oncol; 2021; 11():701736. PubMed ID: 34760688
[TBL] [Abstract][Full Text] [Related]
18. A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
Huang S; Sun L; Hou P; Liu K; Wu J
Front Immunol; 2022; 13():944898. PubMed ID: 36148220
[TBL] [Abstract][Full Text] [Related]
19. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
Dai K; Liu C; Guan G; Cai J; Wu L
BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
[TBL] [Abstract][Full Text] [Related]
20. A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma.
Luo Y; Liu H; Fu H; Ding GS; Teng F
Front Immunol; 2022; 13():974377. PubMed ID: 36458010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
